{"url":"https://lda.senate.gov/api/v1/filings/447681ed-e8af-4e2b-a0bf-822acc17bb9e/","filing_uuid":"447681ed-e8af-4e2b-a0bf-822acc17bb9e","filing_type":"2A","filing_type_display":"2nd Quarter - Amendment","filing_year":2010,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/447681ed-e8af-4e2b-a0bf-822acc17bb9e/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"William N. LaForge, Shareholder","dt_posted":"2010-07-20T18:28:28.223000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1120 20th Street, N.W.","registrant_address_2":"Suite 700 North","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20036","registrant":{"id":42741,"url":"https://lda.senate.gov/api/v1/registrants/42741/","house_registrant_id":33542,"name":"WINSTEAD PC","description":"Law Firm","address_1":"401 Congress Avenue","address_2":"Suite 2100","address_3":null,"address_4":null,"city":"Austin","state":"TX","state_display":"Texas","zip":"78701","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JAMES L. BAYLESS, JR.","contact_telephone":"+1 512-370-2851","dt_updated":"2022-04-06T16:08:15.500720-04:00"},"client":{"id":152593,"url":"https://lda.senate.gov/api/v1/clients/152593/","client_id":734,"name":"AMGEN CORPORATION","general_description":null,"client_government_entity":false,"client_self_select":false,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-03"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Implementation of P.L. 111-148, \"Patient Protection and Affordable Care Act\" and Implementation of P.L. 111-152, \"Health Care and Education Reconciliation Act\" (End Stage Renal Disease)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":46260,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":"N","last_name":"LAFORGE","suffix":null,"suffix_display":null},"covered_position":"Shareholder","new":false}],"government_entities":[{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}